Intelligent Bio Solutions Inc. (INBS)
USD 1.21
(0.83%)
USD 1.21
(0.83%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -6.38 USD | 39.7% |
| 2023 | -10.58 USD | 6.62% |
| 2022 | -11.33 USD | 30.15% |
| 2021 | -16.22 USD | -81.84% |
| 2020 | -8.92 USD | 57.54% |
| 2019 | -21.01 USD | -43.9% |
| 2018 | -14.60 USD | -1374.75% |
| 2017 | -0.99 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - USD | 39.7% |
| 2024 Q1 | -1.25 USD | 1.98% |
| 2024 Q2 | -2.07 USD | 16.53% |
| 2024 Q3 | -1.43 USD | 30.92% |
| 2024 Q4 | -1.75 USD | -22.38% |
| 2023 Q4 | -2.53 USD | 63.17% |
| 2023 FY | - USD | 6.62% |
| 2023 Q3 | -6.87 USD | -1126.79% |
| 2023 Q2 | -0.56 USD | 71.28% |
| 2023 Q1 | -1.95 USD | 41.79% |
| 2022 Q2 | -5.58 USD | -127.76% |
| 2022 Q4 | -3.35 USD | -55.81% |
| 2022 Q3 | -2.15 USD | 61.47% |
| 2022 Q1 | -2.45 USD | -51.23% |
| 2022 FY | - USD | 46.48% |
| 2021 Q4 | -1.62 USD | 74.53% |
| 2021 Q1 | -2.98 USD | -131.01% |
| 2021 Q2 | -5.52 USD | -85.23% |
| 2021 FY | - USD | -244.23% |
| 2021 Q3 | -6.36 USD | -15.22% |
| 2020 Q1 | -2.14 USD | 76.41% |
| 2020 FY | - USD | 49.38% |
| 2020 Q3 | -0.32 USD | 93.82% |
| 2020 Q4 | -1.29 USD | -303.13% |
| 2020 Q2 | -5.18 USD | -142.06% |
| 2019 Q3 | -4.47 USD | 0.0% |
| 2019 FY | - USD | 0.16% |
| 2019 Q4 | -9.07 USD | -102.91% |
| 2019 Q1 | -4.43 USD | 18.57% |
| 2018 Q3 | -2.44 USD | 0.0% |
| 2018 Q4 | -5.44 USD | -122.95% |
| 2018 FY | - USD | -2240.38% |
| 2017 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -402.362% |
| Applied DNA Sciences, Inc. | -15.21 USD | 58.054% |
| Aspira Women's Health Inc. | -1.81 USD | -252.486% |
| Biodesix, Inc. | -0.64 USD | -896.875% |
| BioNexus Gene Lab Corp. | -0.17 USD | -3652.941% |
| bioAffinity Technologies, Inc. | -0.91 USD | -601.099% |
| bioAffinity Technologies, Inc. | -0.91 USD | -601.099% |
| Bionano Genomics, Inc. | -6.81 USD | 6.314% |
| CareDx, Inc | -3.54 USD | -80.226% |
| Check-Cap Ltd. | -3.00 USD | -112.667% |
| Castle Biosciences, Inc. | -2.14 USD | -198.131% |
| DarioHealth Corp. | -1.93 USD | -230.57% |
| Exact Sciences Corporation | -1.13 USD | -464.602% |
| Fulgent Genetics, Inc. | -5.63 USD | -13.321% |
| Guardant Health, Inc. | -4.28 USD | -49.065% |
| ICON Public Limited Company | 7.46 USD | 185.523% |
| IDEXX Laboratories, Inc. | 10.17 USD | 162.734% |
| Illumina, Inc. | -7.35 USD | 13.197% |
| iSpecimen Inc. | -1.23 USD | -418.699% |
| Standard BioTools Inc. | -0.94 USD | -578.723% |
| MDxHealth SA | -1.66 USD | -284.337% |
| 23andMe Holding Co. | -1.40 USD | -355.714% |
| Medpace Holdings, Inc. | 9.20 USD | 169.348% |
| Myriad Genetics, Inc. | -1.39 USD | -358.993% |
| Mainz Biomed B.V. | -1.62 USD | -293.827% |
| ENDRA Life Sciences Inc. | -1.11 USD | -474.775% |
| NeoGenomics, Inc. | -0.70 USD | -811.429% |
| Neogen Corporation | -0.04 USD | -14566.667% |
| Inotiv, Inc. | -4.10 USD | -55.61% |
| Natera, Inc. | -3.78 USD | -68.783% |
| OpGen, Inc. | -41.47 USD | 84.615% |
| OPKO Health, Inc. | -0.25 USD | -2452.0% |
| Psychemedics Corporation | -0.72 USD | -786.111% |
| Prenetics Global Limited | -5.58 USD | -14.337% |
| Prenetics Global Limited | -5.58 USD | -14.337% |
| Precipio, Inc. | -4.51 USD | -41.463% |
| Personalis, Inc. | -2.25 USD | -183.556% |
| RadNet, Inc. | 0.05 USD | 13419.415% |
| Sera Prognostics, Inc. | -1.16 USD | -450.0% |
| Sotera Health Company | 0.18 USD | 3644.444% |
| Neuronetics, Inc. | -1.05 USD | -507.619% |
| Star Equity Holdings, Inc. | 7.42 USD | 185.984% |
| Star Equity Holdings, Inc. | 7.42 USD | 185.984% |
| Trinity Biotech plc | -3.14 USD | -103.185% |
| T2 Biosystems, Inc. | -19.19 USD | 66.754% |
| Twist Bioscience Corporation | -3.60 USD | -77.222% |
| Exagen Inc. | -1.34 USD | -376.119% |